Overview of Dr. Tew
Dr. William Tew is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice 18 years. He specializes in gynecologic cancer and hematologic oncology and is experienced in gynecologic oncology and geriatric assessment.
Office
Memorial Sloan Kettering Cancer Center Bergen
225 Summit Avenue
New York, NY 10021- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
- NYU Grossman School of MedicineResidency, Internal Medicine, 1999 - 2003
- University of Rochester School of Medicine and DentistryClass of 1999
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2019 - 2025
- NY State Medical License 2000 - 2024
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Start of enrollment: 2004 Jan 01
- Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Start of enrollment: 2004 Jan 01
- Assessment Tool for Older Patients With Cancer Start of enrollment: 2006 Dec 19
- Join now to see all
Publications & Presentations
PubMed
- Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.Qin Zhou, Alexia Iasonos, Roisin E O'Cearbhaill, Kara Long Roche, Sarah Ehmann, Clarissa Lam, Rachel N Grisham, William P Tew, Oliver Zivanovic, Yukio Sonoda, Dennis S...> ;Gynecologic Oncology. 2024 Apr 18
- Top advances of the year: Ovarian cancer.Kohn, E., Lumish, M., Tew, W.> ;Cancer. 2024 Mar 15
- Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian can...Boerner, T., Lam, C., Basaran, D., Long Roche, K., Liu, Y., Grisham, R., Tew, W., Zivanovic, O., Abu-Rustum, N., Gardner, G., Sonoda, Y., Chi, D., Soff, G., Jewell, E.> ;International Journal of Gynecological Cancer. 2023 Dec 7
- Join now to see all
Journal Articles
- A Phase 1 Dose-Escalation Study of Intraperitoneal Cisplatin, intravenous/intraperitoneal Paclitaxel, Bevacizumab, and Olaparib for Newly Diagnosed Ovarian CancerKaren A Cadoo, Roisin E O'Cearbhaill, Dmitriy Zamarin, Paul J Sabbatini, William P Tew, Carol Aghajanian, Jason A Konner, Gynecologic Oncology
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
- Memorial Sloan Kettering BergenMontvale, New Jersey
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: